Stemtech Stock Buy Hold or Sell Recommendation
| STEK Stock | USD 0.05 0 5.66% |
Given the investment horizon of 90 days and complete risk avoidance on your part, our recommendation regarding Stemtech is 'Strong Sell'. The recommendation algorithm takes into account all of Stemtech's available fundamental, technical, and predictive indicators you will find on this site.
Check out Stemtech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Stemtech and provide practical buy, sell, or hold advice based on investors' constraints. Stemtech. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in income.
Stemtech |
Execute Stemtech Buy or Sell Advice
The Stemtech recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Stemtech. Macroaxis does not own or have any residual interests in Stemtech or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Stemtech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Out of control | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Stemtech Trading Alerts and Improvement Suggestions
| Stemtech is way too risky over 90 days horizon | |
| Stemtech has some characteristics of a very speculative penny stock | |
| Stemtech appears to be risky and price may revert if volatility continues | |
| Stemtech currently holds 219.47 K in liabilities. Stemtech has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Stemtech until it has trouble settling it off, either with new capital or with free cash flow. So, Stemtech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Stemtech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Stemtech to invest in growth at high rates of return. When we think about Stemtech's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 4.32 M. Net Loss for the year was (7.08 M) with profit before overhead, payroll, taxes, and interest of 3.3 M. | |
| Stemtech currently holds about 399.73 K in cash with (1.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 64.0% of the company outstanding shares are owned by corporate insiders |
Stemtech Returns Distribution Density
The distribution of Stemtech's historical returns is an attempt to chart the uncertainty of Stemtech's future price movements. The chart of the probability distribution of Stemtech daily returns describes the distribution of returns around its average expected value. We use Stemtech price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Stemtech returns is essential to provide solid investment advice for Stemtech.
| Mean Return | 0.87 | Value At Risk | -12.06 | Potential Upside | 9.04 | Standard Deviation | 16.09 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Stemtech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Stemtech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Stemtech or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Stemtech's price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Stemtech otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.62 | |
β | Beta against Dow Jones | 2.09 | |
σ | Overall volatility | 16.47 | |
Ir | Information ratio | 0.05 |
Stemtech Volatility Alert
Stemtech is displaying above-average volatility over the selected time horizon. Stemtech is a penny stock. Although Stemtech may be in fact a good investment, many penny otc stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Stemtech. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Stemtech instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Stemtech Fundamentals Vs Peers
Comparing Stemtech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Stemtech's direct or indirect competition across all of the common fundamentals between Stemtech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Stemtech or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Stemtech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Stemtech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Stemtech to competition |
| Fundamentals | Stemtech | Peer Average |
| Return On Asset | -0.75 | -0.14 |
| Profit Margin | (1.85) % | (1.27) % |
| Operating Margin | (1.34) % | (5.51) % |
| Current Valuation | 8.79 M | 16.62 B |
| Shares Outstanding | 48.63 M | 571.82 M |
| Shares Owned By Insiders | 63.60 % | 10.09 % |
| Price To Sales | 1.54 X | 11.42 X |
| Revenue | 4.32 M | 9.43 B |
| Gross Profit | 3.3 M | 27.38 B |
| EBITDA | 1.58 M | 3.9 B |
| Net Income | (7.08 M) | 570.98 M |
| Cash And Equivalents | 399.73 K | 2.7 B |
| Cash Per Share | 0.01 X | 5.01 X |
| Total Debt | 219.47 K | 5.32 B |
| Current Ratio | 0.03 X | 2.16 X |
| Book Value Per Share | (0.08) X | 1.93 K |
| Cash Flow From Operations | (1.91 M) | 971.22 M |
| Earnings Per Share | 0.10 X | 3.12 X |
| Number Of Employees | 4 | 18.84 K |
| Market Capitalization | 6.52 M | 19.03 B |
| Total Asset | 5.72 M | 29.47 B |
| Z Score | 17.4 | 8.72 |
| Net Asset | 5.72 M |
Stemtech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Stemtech . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 0.05 | |||
| Day Typical Price | 0.05 | |||
| Price Action Indicator | (0) | |||
| Period Momentum Indicator | (0) | |||
| Relative Strength Index | 71.34 |
About Stemtech Buy or Sell Advice
When is the right time to buy or sell Stemtech? Buying financial instruments such as Stemtech OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Stemtech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Dividend Beast Thematic Idea Now
Dividend Beast
An experimental equal-weighted theme of equities with high dividend yield and solid fundamentals based on Macroaxis rating system. The Dividend Beast theme has 69 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Dividend Beast Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Stemtech OTC Stock
Stemtech financial ratios help investors to determine whether Stemtech OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stemtech with respect to the benefits of owning Stemtech security.